How Many Athersys, Inc. (NASDAQ:ATHX)’s Analysts Are Bearish?

Athersys, Inc. (NASDAQ:ATHX) Logo
Investors sentiment increased to 2.1 in Q2 2019. Its up 0.97, from 1.13 in 2019Q1. It improved, as 6 investors sold Athersys, Inc. shares while 15 reduced holdings. 14 funds opened positions while 30 raised stakes. 32.17 million shares or 11.85% more from 28.76 million shares in 2019Q1 were reported.
Wells Fargo Mn reported 0% of its portfolio in Athersys, Inc. (NASDAQ:ATHX). National Bank & Trust Of Montreal Can invested in 10,979 shares or 0% of the stock. Northwestern Mutual Wealth Management stated it has 2,500 shares or 0% of all its holdings. State Of Wisconsin Board reported 154,500 shares. Raymond James And Associates invested 0% in Athersys, Inc. (NASDAQ:ATHX). Envestnet Asset Mngmt stated it has 25,200 shares. Citigroup has 39,914 shares for 0% of their portfolio. Proshare Advsr Limited Co has 12,346 shares for 0% of their portfolio. The Massachusetts-based Geode Capital Ltd Liability Corporation has invested 0% in Athersys, Inc. (NASDAQ:ATHX). Comml Bank Of Mellon Corp invested 0% of its portfolio in Athersys, Inc. (NASDAQ:ATHX). Principal Inc accumulated 16,020 shares or 0% of the stock. Voya Inv Mngmt Limited Liability Co holds 0% of its portfolio in Athersys, Inc. (NASDAQ:ATHX) for 54,014 shares. Moreover, Glenmede Tru Commerce Na has 0% invested in Athersys, Inc. (NASDAQ:ATHX). Oppenheimer has 10,000 shares for 0% of their portfolio. Morgan Stanley holds 28,392 shares or 0% of its portfolio.

Athersys, Inc. (NASDAQ:ATHX) Ratings Coverage

Among 3 analysts covering Athersys (NASDAQ:ATHX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Athersys has $1100 highest and $6 lowest target. $8.33’s average target is 455.33% above currents $1.5 stock price. Athersys had 4 analyst reports since March 15, 2019 according to SRatingsIntel. The firm earned “Buy” rating on Friday, March 15 by Needham. Maxim Group maintained Athersys, Inc. (NASDAQ:ATHX) rating on Friday, March 15. Maxim Group has “Buy” rating and $8 target. Below is a list of Athersys, Inc. (NASDAQ:ATHX) latest ratings and price target changes.

26/08/2019 Broker: Dawson James Rating: Buy New Target: $11.0000 Initiates Coverage On
19/05/2019 Broker: BidaskScore Rating: Sell Upgrade
15/03/2019 Broker: Needham Rating: Buy New Target: $6 Maintain
15/03/2019 Broker: Maxim Group Rating: Buy New Target: $8 Maintain

The stock increased 1.35% or $0.02 during the last trading session, reaching $1.5. About 671,773 shares traded or 14.14% up from the average. Athersys, Inc. (NASDAQ:ATHX) has declined 26.06% since September 13, 2018 and is downtrending. It has underperformed by 26.06% the S&P500.

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company has market cap of $229.02 million. The Company’s clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. It currently has negative earnings. The companyÂ’s lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which has completed Phase 2 study for treating patients suffering from moderate and severe ischemic stroke; that is in Phase 2 clinical study for treating patients with acute myocardial infarction; and, which is in Phase 1/2 clinical study for treating patients with acute respiratory distress syndrome, as well as completed Phase 1 clinical study for patients suffering from leukemia or various other blood-borne cancers.

More notable recent Athersys, Inc. (NASDAQ:ATHX) news were published by: which released: “Here’s Why Athersys Rose as Much as 15.2% Today – Yahoo Finance” on May 14, 2019, also with their article: “Volatility 101: Should Athersys (NASDAQ:ATHX) Shares Have Dropped 25%? – Yahoo Finance” published on May 24, 2019, published: “Athersys: Stem Cell Therapy For Ischemic Stroke – Seeking Alpha” on May 13, 2019. More interesting news about Athersys, Inc. (NASDAQ:ATHX) were released by: and their article: “Do Institutions Own Shares In Athersys, Inc. (NASDAQ:ATHX)? – Yahoo Finance” published on July 31, 2019 as well as‘s news article titled: “Athersys Reports First Quarter 2019 Results Nasdaq:ATHX – GlobeNewswire” with publication date: May 08, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.